This podcast series spotlights innovations in cardiovascular medicine and clinical research. We explore coronary inflammation as a new frontier in risk management, featuring insights on residual risk, landmark trials, and Abcentra’s monoclonal antibody approach. Then we delve into advanced imaging and trial design strategies for targeted therapies, emphasizing precision medicine and the role of novel endpoints in accelerating development. Together, these conversations highlight emerging science, collaborative solutions, and the shift toward personalized cardiovascular care.
Sign up to track rankings and reviews from Spotify, Apple Podcasts and more.